China Pharma Holdings, Inc. SEC filings CPHI

China Pharma Holdings, Inc. has 426 filings in SEC EDGAR's recent list, going back to Feb 15, 2000. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 22, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

China Pharma Holdings, Inc. SEC filings
Form Description Filed Period
424B5 Prospectus supplement Jul 23, 2026 —
424B5 Prospectus supplement Dec 13, 2024 —
S-3/A Amendment no. 1 to form s-3 Feb 6, 2024 —
S-3 Shelf registration Jan 12, 2024 —
S-8 Employee stock plan registration Oct 24, 2022 —
424B5 Prospectus supplement Dec 16, 2021 —
S-3 Shelf registration Jan 8, 2021 —
S-8 Employee stock plan registration Dec 21, 2020 —
POS AM Filing Feb 3, 2010 —
S-3 Shelf registration Dec 28, 2009 —
424B3 Prospectus Oct 1, 2009 —
424B3 Prospectus Sep 28, 2009 —
424B3 Prospectus Jun 30, 2009 —
424B3 Prospectus May 4, 2009 —
424B3 Prospectus Mar 23, 2009 —
424B3 Prospectus Aug 14, 2008 —
S-1/A Amended registration statement Jul 29, 2008 —
S-1 Registration statement Jul 11, 2008 —
424B3 Prospectus May 8, 2007 —
424B3 Prospectus Mar 16, 2006 —

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CPHI (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Hainan Province, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1106644
Former names
TS ELECTRONICS INC (until May 4, 2006); SOFTSTONE INC (until Aug 18, 2003); SOFTSTONE INC /DE/ (until Jan 27, 2003); KILKENNY ACQUISITION CORP (until Mar 30, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.